Synlogic Inc

NASDAQ:SYBX   3:12:08 PM EDT
0.96
-0.02 (-1.54%)
Products

Synlogic Granted FDA Fast Track Designation For SYNB1353 For The Treatment Of Homocystinuria

Published: 08/23/2022 12:03 GMT
Synlogic Inc (SYBX) - Synlogic Granted FDA Fast Track Designation for Synb1353 for the Treatment of Homocystinuria (hcu).
Synlogic Inc - Synlogic Expects to Share Results From Phase 1 Study of Synb1353 in Healthy Volunteers by End of 2022.